Abstract
Inhaled nitric oxide is a selective pulmonary vasodilator that serves integral diagnostic and therapeutic roles in the clinical management of near-term and term newborns with hypoxemic respiratory failure and pulmonary hypertension. Its proper use and potential limitations in current clinical practice are reviewed.
MeSH terms
-
Administration, Inhalation
-
Clinical Trials as Topic
-
Echocardiography
-
Extracorporeal Membrane Oxygenation
-
Humans
-
Infant, Newborn
-
Nitric Oxide / administration & dosage*
-
Persistent Fetal Circulation Syndrome / drug therapy*
-
Vasodilator Agents / administration & dosage*
Substances
-
Vasodilator Agents
-
Nitric Oxide